Boston Scientific stock jumped Wednesday after the medtech giant easily beat Wall Street's fourth-quarter expectations and its own guidance.

The system also includes visible, directional emitters for consistent energy delivery in the treatment of the calcified lesions. Boston Scientific initially developed the concept for the Bolt IVL ...

The business is seeking regulatory licenses in the U.S. and Europe; the system contains directed emitters for constant energy distribution. Boston Scientific owns 26% of Bolt Medical and has been ...